2005
December 14, 2005: Cytokinetics Announces Seven Poster Presentations at the 45th Annual American Society of Cell Biology Meeting
December 13, 2005: Cytokinetics Announces Selection of Development Candidate Directed to Second Mitotic Kinesin Target
December 8, 2005: Cytokinetics Announces Presentation of Ispinesib data at San Antonio Breast Cancer Symposium
December 7, 2005: Cytokinetics Announces Selection of CK-1827452 as Development Candidate for Chronic Heart Failure
December 7, 2005: Cytokinetics Announces Seven Posters to be Presented at the 45th Annual American Society of Cell Biology Meeting
December 2, 2005: Cytokinetics Sponsors Fourth Special Interest Subgroup on Function and Regulation of Actin-Myosin Interactions
December 1, 2005: Cytokinetics Announces Interim Phase II Breast Cancer data for Ispinesib to be presented at San Antonio Breast Cancer Symposium
November 22, 2005: Cytokinetics to Present at the Lazard Capital Markets Life Sciences Conference
November 17, 2005: Cytokinetics Announces Clinical and Non-Clinical Results for Ispinesib at the 2005 Annual AACR-NCI-EORTC Meeting
November 11, 2005: Cytokinetics to Present at the Credit Suisse First Boston Health Care Conference
November 10, 2005: Cytokinetics Announces Clinical and Non-Clinical Data on Ispinesib to be Presented at the 2005 AACR-NCI-EORTC International Meeting
October 31, 2005: Cytokinetics to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference
October 28, 2005: Cytokinetics Secures $75 Million Committed Equity Financing Facility
October 26, 2005: Cytokinetics, Incorporated Reports Third quarter 2005 Financial Results
October 19, 2005: Cytokinetics to Announce Third Quarter Results on October 26, 2005
October 12, 2005: Cytokinetics to Present at BIO InvestorForum 2005
September 27, 2005: Cytokinetics Provides Clinical Trials Update for Ispinesib (SB-715992)
September 19, 2005: Cytokinetics Presents Data on CK-1827452 at the 2005 Annual Heart Failure Society of America Meeting; Non-Clinical Research Findings Support Advancement of Drug Candidate
September 12, 2005: Cytokinetics to Present Non-Clinical Data On CK-1827452 At the 2005 Annual Heart Failure Society of America Meeting
September 6, 2005: Cytokinetics to Present at the Bear Stearns 18th Annual Healthcare Conference
September 2, 2005: Cytokinetics to Present at the 12th Annual NewsMakers in the Biotech Industry Conference
July 27, 2005: Cytokinetics Presents Data from Heart Failure Program; Presentation Supports Advancement of CK-1827452 Towards Clinical Development
July 20, 2005: Cytokinetics to Announce Second Quarter Results on July 27, 2005
June 14, 2005: Cytokinetics Files Shelf Registration Statement
June 7, 2005: Cytokinetics to Present at the Goldman Sachs Twenty-Sixth Annual Global Healthcare Conference
May 27, 2005: Cytokinetics to Present at the Pacific Growth Equities 2005 Life Sciences Growth Conference
May 25, 2005: Cytokinetics to Present at the Friedman Billings Ramsey 9th Annual Growth Investor Conference
May 18, 2005: Cytokinetics to Present at the Needham & Company Fourth Annual Biotechnology Conference
May 12, 2005: Cytokinetics to Hold Annual Meeting of Stockholders
May 10, 2005: Cytokinetics to Present at the Banc of America Securities Health Care Conference 2005
April 27, 2005: Cytokinetics, Incorporated Reports First Quarter 2005 Financial Results; Company Provides Update on Development Programs
April 25, 2005: Cytokinetics to Present at the Deutsche Bank 30th Annual Health Care Conference
April 20, 2005: Cytokinetics to Announce First Quarter Results on April 27, 2005
April 5, 2005: Cytokinetics Announces Changes to Board of Directors
March 31, 2005: Cytokinetics to Present at the BioCentury Future Leaders in the Biotech Industry Conference
March 3, 2005: Cytokinetics Announces Selection of Heart Failure Drug Development Candidate
February 16, 2005: Cytokinetics to Present at the BIO CEO & Investor Conference 2005
February 3, 2005: Cytokinetics, Incorporated Reports Fourth Quarter and Year End 2004 Financial Results; Company Provides Update on Development Programs
January 27, 2005: Cytokinetics to Release Fourth Quarter and Year End 2004 Financial Results on February 3, 2005
2004
December 16, 2004: Cytokinetics Announces the Initiation of an Additional Phase II Clinical Trial for Lead Cancer Drug Candidate
November 30, 2004: Cytokinetics Announces Eleven Abstracts to Be Presented at the 44th Annual American Society of Cell Biology Meeting
November 23, 2004: Cytokinetics to Present at the Lazard Life Sciences Conference
November 11, 2004: Cytokinetics to Present at the Credit Suisse First Boston Annual Heathcare Conference
November 8, 2004: Cytokinetics Announces Data from Heart Failure Drug Discovery Program Presented at the 2004 Scientific Sessions of the American Heart Association
November 3, 2004: Cytokinetics Announces Research Data from Heart Failure Program at the American Heart Association Annual Meeting
November 2, 2004: Cytokinetics Announces Research Data from Heart Failure Program at the American Heart Association Annual Meeting
October 22, 2004: Cytokinetics to Present at the Rodman and Renshaw Conference
October 21, 2004: Cytokinetics, Incorporated Reports Third Quarter Financial Results; Company Reports Progress in Oncology and Cardiovascular Programs
October 14, 2004: Cytokinetics to Announce Third Quarter Results on October 21, 2004
October 7, 2004: Cytokinetics to Present at the Bio Emerging Company Investor Forum Conference
July 23, 2004: Cytokinetics to Present at the Banc of America Securities Specialty Pharmaceuticals Conference
July 21, 2004: Cytokinetics to Announce Second Quarter Results on July 28, 2004
June 10, 2004: Cytokinetics to Present at the Third Annual Needham Biotechnology Conference
June 9, 2004: Cytokinetics to Announce First Quarter Results on June 16, 2004
June 8, 2004: Cytokinetics To Present At Pacific Growth Equities’ Life Sciences Growth Conference
June 3, 2004: Cytokinetics to Present at Goldman Sachs Twenty Fifth Annual Global Healthcare Conference
May 27, 2004: Cytokinetics to Present at Friedman, Billings, Ramsey’s 8th Annual Growth Investor Conference
May 17, 2004: Cytokinetics to Present at Bank of America Securities Health Care Conference
May 13, 2004: Cytokinetics Announces the Initiation of Phase I Clinical Trial for SB-743921 in Cancer Patients with Solid Tumors
April 29, 2004: Cytokinetics, Incorporated Announces Its Initial Public Offering
March 29, 2004: Cytokinetics, Incorporated Announces Its Initial Public Offering
January 27, 2004: Cytokinetics, Inc. Files for Initial Public Offering
2003
December 18, 2003: Cytokinetics Announces Technology Development Collaboration with AstraZeneca Focused on Predictive Toxicity
December 11, 2003: Cytokinetics Sponsors Third Special Interest Subgroup on Interface Between Small Molecule Chemistry and Cell Biology
April 28, 2003: Cytokinetics Completes Mezzanine Stage Financing; Two New Board Members Named
2002
December 12, 2002: Cytokinetics Sponsors Second Special Interest Subgroup on Cytoskeletal Pharmacology and Human Disease
August 12, 2002: Cytokinetics Announces the Initiation of Phase I Clinical Trial
January 9, 2002: Cytokinetics Announces Cytometrix™ Technologies Development Partner Program
January 3, 2002: Exelixis And Cytokinetics Establish Chemistry Collaboration
2001
September 21, 2001: Cytokinetics Announces Milestone Payment on Selection of Oncology Development Candidate By GlaxoSmithKline
June 25, 2001: Cytokinetics and GlaxoSmithKline Form Major Strategic Alliance in Cancer Drug Discovery
2000
December 8, 2000: Cytokinetics Sponsors Special Interest Subgroup On The Cytoskeleton And Mechanisms Of Disease
November 27, 2000: Cytokinetics Completes $55.0 Million Series C Financing
1999
September 9, 1999: Cytokinetics Closes $20.0 Million Series B Financing
1998
December 16, 1998: Cytokinetics, Inc. Formed to Leverage Cytoskeleton for Drug Discovery and Bioinformatics